FindMyKOL

Arash Mostaghimi, MD, MPH

Enriched profile

Vice Chair of Clinical Trials and Innovation · Brigham and Women's Hospital

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyDermatologyFocusDermatology and Skin Diseases+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Arash Mostaghimi is Vice Chair of Clinical Trials and Innovation at Brigham and Women's Hospital. OpenAlex indexes 551 publications with 7,809 citations (h-index 45); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the FindMyKOL directory.

Data verified 9 Nov 2026

Overview

Updated 20 Nov 2026

Arash Mostaghimi, MD, MPA, MPH, is Vice Chair of Clinical Trials and Innovation at Brigham and Women's Hospital. The public record shows 551 publications with 7,809 citations (h-index 45), centered on Dermatology and Skin Diseases, Hair Growth and Disorders, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 13 companies.

  • Most recent indexed publication: 2026 · Journal of the European Academy of Dermatology and Venereology
  • Top research focus: Dermatology and Skin Diseases
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 20 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Alopecia1 trialAlopecia Areata1 trialAcne / HidradenitisAsthmaAtopic Dermatitis / EczemaAtrial FibrillationBipolar DisorderCushing's SyndromeDyslipidemia / Lipid DisordersIBD (Crohn's / UC)Leukemia (AML/ALL/CML/CLL)Lupus (SLE)LymphomaMDS / MPNMelanomaMultiple MyelomaObesityOsteoporosisPsoriasis (Derm)Prostate CancerPsoriasis / Psoriatic ArthritisRheumatoid ArthritisSarcomaSepsis / Serious BacterialAnkylosing Spondylitis / SpASubstance Use Disorders

Research focus

OpenAlex concept fingerprint
Dermatology and Skin DiseasesHair Growth and DisordersPsoriasis: Treatment and Pathogenesismelanin and skin pigmentationAutoimmune and Inflammatory Disorders

Drugs & molecules

across trials, industry payments and publications
Spevigogeneric · SpesolimabClinical trials—Industry payments31Publications2Olumiantgeneric · BaricitinibClinical trials—Industry payments4Publications3Litfulogeneric · RitlecitinibClinical trials—Industry payments5Publications1Leqselvigeneric · DeuruxolitinibClinical trials—Industry payments35Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments17Publications—Cibinqogeneric · AbrocitinibClinical trials—Industry payments7Publications—Eucrisageneric · CrisaboroleClinical trials—Industry payments4Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments3Publications—Adbrygeneric · TralokinumabClinical trials—Industry payments1Publications—SIMPONI ARIAClinical trials—Industry payments1Publications—Stelarageneric · UstekinumabClinical trials—Industry payments1Publications—Tremfyageneric · GuselkumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials1Industry payments16Abbvie Inc.Clinical trials—Industry payments50Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments47Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments41Pfizer Inc.Clinical trials—Industry payments36Boehringer Ingelheim International GmbHClinical trials—Industry payments35Digital Diagnostics Inc.Clinical trials—Industry payments3UCB, Inc.Clinical trials—Industry payments3Arcutis Biotherapeutics, Inc.Clinical trials—Industry payments2Janssen Biotech, Inc.Clinical trials—Industry payments1LEO Pharma Inc.Clinical trials—Industry payments1Lilly USA, LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
551publications

Publications indexed by OpenAlex, matched via ORCID. 43 in PubMed. Counts exclude supporting files.

7,809citations

Citations across these publications.

45h-index

H-index from these publications. i10-index 159.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

75 Francis St, Boston, MA 02115

From the cited public source.Collected 9 Nov 2026.View source ↗

Clinical trials

Updated 9 Nov 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 9 Nov 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

  • SUN PHARMACEUTICAL INDUSTRIES INC.
    Program year202535 payments
    $52,744
  • Boehringer Ingelheim International GmbH
    Program year20257 payments
    $45,377
  • ABBVIE INC.
    Program year202520 payments
    $18,189
All 32 payment records: search, sort and filter.Explore →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    37.4%
    Azole Antifungal22.6%
    Ketoconazole71%Fluconazole29%
    Part D<11 patients
    Tetracycline-class Drug6%
    Doxycycline Monohydrate100%
    Part D<11 patients

    + 2 more classes in this area

  • Dermatology

    17.1%
    Corticosteroid12.9%
    Triamcinolone Acetonide100%
    Part D≥28 patients
    Interleukin-4 Receptor alpha Antagonist4.3%
    Dupixent Pen100%
    Part D<11 patients
  • Cancer & immunology

    16.3%
    TNF inhibitor6.3%
    Humira Pen100%
    Part D<11 patients
    JAK inhibitor3.4%
    Olumiant100%
    Part D<11 patients

    + 2 more classes in this area

All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)6.3% facility · 93.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 9 Nov 2026

67 congress contributions (2019–2026) across AAD, ASCO, ISPOR, SID per OpenAlex. The most recent:

Publications

Updated 9 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 9 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

John S. Barbieri55Cara Joyce53Priya Manjaly35Brett King33Sara Jiayang Li32Nicholas Theodosakis31Samantha Gregoire31Maryanne Makredes Senna30Kathie P. Huang30Ursula Biba30Elizabeth Tkachenko29Eric Xia28Sophia Ly28Robert G. Micheletti26Megan H. Noe26David G. Li25Alex G. Ortega‐Loayza24Kanika Kamal23Sean B. Singer23Natasha Atanaskova Mesinkovska22Joseph Frank Merola22Jane Han21Yves Dutronc21Benjamin Harris Kaffenberger21Misha A. Rosenbach20Caroline A. Nelson19Maria C. Schneeweiss19Adam Faletsky19Lara Drake19Rodney Daniel Sinclair18Rebecca Ivy Hartman18Christian Thoma18Manabu Ohyama16Sebastian Schneeweiß16Justin Ko16Ahana Gaurav16Nora Bensellam16Guanglei Yu15Ming Tang14Katherine Young14

Online presence

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/arash-mostaghimi-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/arash-mostaghimi

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
  • ResearchGate

    researchgate.net/profile/Arash-Mostaghimi

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/AMostaghimi

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    podcasts.apple.com/us/podcast/9-is-a-med-derm-program-right-for-me-should-i-talk/id1586707149

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/an-interview-with-generalized-pustular-psoriasis/id1604615566

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/episode-8-is-this-dress-an-interview-with-dr/id1552571646

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Other

    connects.catalyst.harvard.edu/Profiles/profile/1240029

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connects.catalyst.harvard.edu ↗
  • Other

    massgeneralbrigham.org/en/doctors/m/arash-mostaghimi-3008623

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →massgeneralbrigham.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 9 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.